4th Quarter - Report
TIBER CREEK GROUP for BRISTOL MYERS SQUIBB
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA. Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).
| Lobbyist | Covered position, as disclosed |
|---|---|
| COREY MALMGREN | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). Issues related to the implementation of the American Relief Act of 2025 (PL 118-158).
| Lobbyist | Covered position, as disclosed |
|---|---|
| COREY MALMGREN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.